Researchers from Howard University will present their findings today at the American Physiological Society's Physiological and Pathophysiological Consequences of Sickle
Cell Disease conference in Washington, D.C.
Not exact matches
Researchers have found a group of circulating tumor
cells in prostate cancer patient blood samples which are linked to the spread of the
disease, according to new research presented at the National Cancer Research Institute (NCRI) Cancer
Conference in Liverpool.
The third and final day of the 2016 Huntington's
Disease Therapeutics
Conference brings updates on
cell replacement therapies including stem
cells; and new ways to assess and model the progression of HD to help understand it and run crucial clinical trials.
«To date, CAR T -
cell trials have thus far shown the highest rate of complete and minimal residual
disease remission rates of any other agent,» explained Bijal Shah, MD, of Moffitt Cancer Center in Tampa, during the National Comprehensive Cancer Network (NCCN) Annual
Conference, held March 22 — 24 in Orlando, Florida.
EMBO
Conference - Advances in Stem
Cell Research: Development, Regeneration and
Disease The 3rd event in this EMBO
Conference Series on Stem
Cells.